PolyNovo Limited (FRA:MFJ)

Market Cap	425.63M +1.1%
Revenue (ttm)	90.82M +16.1%
Net Income	4.45M -44.4%
EPS	0.01 -44.4%
Shares Out	n/a
PE Ratio	95.75
Forward PE	77.14
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.5800
Previous Close	0.6100
Day's Range	0.5800 - 0.5800
52-Week Range	0.4640 - 0.9400
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 26, 2026

About PolyNovo

PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, and Hong Kong. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn. It is also developing hernia devices for hernia repair and solution for ventral hernia and complex abdominal wall reconstruction; Beta Cell implant, a novel intracutaneous ectopic pancreas to tre...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1998
• Employees: 301
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: MFJ

Financial Performance

In fiscal year 2026, PolyNovo's revenue was 149.98 million, an increase of 16.54% compared to the previous year's 128.70 million. Earnings were 7.34 million, a decrease of -44.45%.

Financial numbers in AUD

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 26, 2026

Data Sources Report a data error